Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide and DC Vaccine in Stage IV Melanoma
NCT00313235Phase 2Completed
- Sponsor
- Baylor Scott & White Research Institute
- Start
- Mar 2006
- Primary completion
- Jun 2011
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of autologous dendritic cell vaccine loaded with killed allogeneic melanoma cells in melanoma, sponsored by Baylor Scott & White Research Institute. Started Mar 2006; status: completed.
02
Drugs
autologous dendritic cell vaccine loaded with killed allogeneic melanoma cells
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00313235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00313235.